| dc.contributor.author | Jones, CE | en_US |
| dc.contributor.author | McKnight, A | en_US |
| dc.date.accessioned | 2017-03-13T12:11:12Z | |
| dc.date.issued | 2016-12 | en_US |
| dc.date.submitted | 2017-03-13T12:00:14.687Z | |
| dc.identifier.issn | 0951-7375 | en_US |
| dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/20259 | |
| dc.description.sponsorship | C.E.J. is funded by The Rosetrees Trust and QMUL life Sciences Institute. | en_US |
| dc.format.extent | 609 - 614 | en_US |
| dc.relation.ispartof | CURRENT OPINION IN INFECTIOUS DISEASES | en_US |
| dc.rights | This accepted version is made available under the terms of the Creative Commons Attribution – Non-Commercial (CC BY-NC) license. The final published version can be found here http://dx.doi.org/10.1097/QCO.0000000000000322 | |
| dc.subject | anti-HIV therapies | en_US |
| dc.subject | HIV | en_US |
| dc.subject | host-mediated immunity | en_US |
| dc.subject | restriction factors | en_US |
| dc.title | Retroviral restriction: nature's own solution | en_US |
| dc.type | Article | |
| dc.rights.holder | Copyright 2016 Wolters Kluwer Health, Inc. All rights reserved. | |
| dc.identifier.doi | 10.1097/QCO.0000000000000322 | en_US |
| pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000387205300009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | 6 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 29 | en_US |
